{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T04:45:51Z","timestamp":1771994751597,"version":"3.50.1"},"reference-count":95,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Issues<\/jats:title><jats:p>Substance use disorders are associated with significant physical health comorbidities, necessitating an integrated treatment response. However, service fragmentation can preclude the management of physical health problems during addiction treatment. The aim of this systematic review was to synthesise the recommendations made by clinical practice guidelines for addressing the physical health of people attending alcohol and other drug (AOD) treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Approach<\/jats:title><jats:p>An iterative search strategy of grey literature sources was conducted from September 2020 to February 2021 to identify clinical practice guidelines. Content pertaining to physical health care during AOD treatment was extracted. Quality of guidelines were appraised using the Appraisal of Guidelines Research and Evaluation II (AGREE\u2010II) tool.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>Thirty\u2010three guidelines were included for review. Fourteen guidelines were considered high quality based on AGREE\u2010II scores. Neurological conditions (90.9%) and hepatitis (81.8%) were the most frequent health problems addressed. Most guidelines recommended establishing referral pathways to address physical health comorbidities (90.9%). Guidance on facilitating these referral pathways was less common (42.4%). Guidelines were inconsistent in their recommendations related to oral health, tobacco use, physical activity, nutrition and the use of standardised assessment tools.<\/jats:p><\/jats:sec><jats:sec><jats:title>Implications and Conclusions<\/jats:title><jats:p>Greater consistency and specificity in the recommendations made for integrating physical health care within addiction treatment is needed. Ensuring that recommendations are applicable to the AOD workforce and to treatment services limited by funding and resource constraints should enhance implementation. Future guideline development groups should consider increased consultation with the AOD workforce and inclusion of clinical tools and decision aids to facilitate referral pathways.<\/jats:p><\/jats:sec>","DOI":"10.1111\/dar.13504","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T06:29:39Z","timestamp":1656484179000},"page":"1367-1390","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Systematic review of guidelines for managing physical health during treatment for substance use disorders: Implications for the alcohol and other drug workforce"],"prefix":"10.1111","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0428-2442","authenticated-orcid":false,"given":"Briony","family":"Osborne","sequence":"first","affiliation":[{"name":"School of Psychology, University of Wollongong  Wollongong Australia"},{"name":"Centre for Health Psychology Practice and Research  Wollongong Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3800-7673","authenticated-orcid":false,"given":"Briony","family":"Larance","sequence":"additional","affiliation":[{"name":"School of Psychology, University of Wollongong  Wollongong Australia"},{"name":"Centre for Health Psychology Practice and Research  Wollongong Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowena","family":"Ivers","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine, University of Wollongong  Wollongong Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank P.","family":"Deane","sequence":"additional","affiliation":[{"name":"School of Psychology, University of Wollongong  Wollongong Australia"},{"name":"Centre for Health Psychology Practice and Research  Wollongong Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3409-475X","authenticated-orcid":false,"given":"Laura D.","family":"Robinson","sequence":"additional","affiliation":[{"name":"School of Psychology, University of Wollongong  Wollongong Australia"},{"name":"Centre for Health Psychology Practice and Research  Wollongong Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0500-1865","authenticated-orcid":false,"given":"Peter J.","family":"Kelly","sequence":"additional","affiliation":[{"name":"School of Psychology, University of Wollongong  Wollongong Australia"},{"name":"Centre for Health Psychology Practice and Research  Wollongong Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.53.7.861"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000512"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2009.00075.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012060-00017"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13754"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2011.11.003"},{"key":"e_1_2_9_8_1","first-page":"929","article-title":"Oral health of drug abusers: A review of health effects and care","volume":"42","author":"Shekarchizadeh H","year":"2013","journal-title":"Iran J Public Health"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.07.006"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03660.x"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2012.00465.x"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108557"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13897"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.312461"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2018.01.093"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2011.00298.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2013.806111"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2016.12.001"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494814561819"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-017-0104-7"},{"key":"e_1_2_9_21_1","volume-title":"Principles of Drug Addiction Treatment: A Research\u2010Based Guide","author":"National Institute on Drug Abuse","year":"2018"},{"key":"e_1_2_9_22_1","first-page":"1","volume-title":"Management of physical health conditions in adults with severe mental disorders \u2010 WHO Guidelines","author":"World Health Organization","year":"2018"},{"key":"e_1_2_9_23_1","first-page":"1","volume-title":"Alcohol\u2010use disorders: physical complications \u2010 2017 update","author":"National Institute for Health & Clinical Excellence, National Clinical Guideline Centre","year":"2017"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.05.021"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170958"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-4887-7"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826080903442836"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1071\/PY15097"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.3109\/14659890903580474"},{"key":"e_1_2_9_30_1","volume-title":"Satisfaction, stress & retention among alcohol & other drug workers in Australia","author":"Duraisingam V","year":"2006"},{"key":"e_1_2_9_31_1","volume-title":"Enhancing Alcohol and Other Drug Worker's Wellbeing: A Literature Review","author":"Nicholas R","year":"2017"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/0959523021000002679"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2111"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.02.018"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/0020764014562051"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S22575"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13463"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12871"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2019.1622649"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13197"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2017.09.015"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12083"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2019.1704960"},{"key":"e_1_2_9_44_1","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Institute of Medicine","year":"2011"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_9_46_1","volume-title":"A review of Australian Clinical Guidelines for Methamphetamine Use Disorder","author":"Roche AM","year":"2019"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2010.08.005"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.12145"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agx034"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2017.03.017"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-81"},{"key":"e_1_2_9_52_1","first-page":"1","volume-title":"National community detoxification benzodiazepine guidelines","author":"Ana Liffey Drug Project","year":"2017"},{"key":"e_1_2_9_53_1","first-page":"1","volume-title":"National community detoxification: methadone guidelines","author":"Ana Liffey Drug Project","year":"2017"},{"key":"e_1_2_9_54_1","first-page":"1","volume-title":"Provincial guideline for the clinical management of high\u2010risk drinking and alcohol use disorder","author":"British Columbia Centre on Substance Use","year":"2019"},{"key":"e_1_2_9_55_1","first-page":"1","volume-title":"Provincial Guidelines for Biopsychosocial spiritual Withdrawal Management Services \u2010 Adult","author":"British Columbia Ministry of Health","year":"2017"},{"key":"e_1_2_9_56_1","first-page":"1","volume-title":"Coexisting severe mental illness and substance misuse: community health and social care services","author":"National Institute for Health and Care Excellence","year":"2016"},{"key":"e_1_2_9_57_1","unstructured":"Canadian Research & Initiative on Substance Misuse.National guideline for the clinical management of opioid use disorders.Canada:Canadian Institutes of Health Research (CIHR) the Canadian Research & Initiative on Substance Misuse (CRISM);2018. p.1\u2013275."},{"key":"e_1_2_9_58_1","first-page":"1","volume-title":"Drug misuse and dependence: UK guidelines on clinical management","author":"Department of Health IEWG","year":"2017"},{"key":"e_1_2_9_59_1","first-page":"1","volume-title":"Methamphetamine Treatment Guidelines: Practice Guidelines for Health Professionals","author":"Grigg J","year":"2018"},{"key":"e_1_2_9_60_1","first-page":"1","volume-title":"Guidelines on the management of co\u2010occurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings","author":"Marel C","year":"2016"},{"key":"e_1_2_9_61_1","first-page":"1","volume-title":"Consensus\u2010based clinical practice guideline for the management of volatile substance use in Australia","author":"National Health and Medical Research Council","year":"2011"},{"key":"e_1_2_9_62_1","first-page":"1","volume-title":"Alcohol\u2010use disorders, The NICE guideline on diagnosis, assessment and management of harmful drinking and alcohol dependence","author":"National Institute for Health & Clinical Excellence [NICE]","year":"2011"},{"key":"e_1_2_9_63_1","first-page":"1","volume-title":"Psychosis with coexisting substance misuse, the NICE guideline on assessment and management In adults and young people","author":"National Institute for Health & Clinical Excellence","year":"2011"},{"key":"e_1_2_9_64_1","first-page":"1","volume-title":"TIP 39: Substance Abuse Treatment and Family Therapy, A Treatment Improvement Protocol (2015 update)","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"key":"e_1_2_9_65_1","first-page":"1","volume-title":"TIP 41: substance abuse treatment: group therapy, a treatment improvement protocol (2015 update)","author":"Substance Abuse and Mental Health ServicesAdministration (SAMHSA)","year":"2015"},{"key":"e_1_2_9_66_1","first-page":"1","volume-title":"TIP 29 substance use disorder treatment for people with physical and cognitive disabilities","author":"Substance Abuse and Mental Health ServicesAdministration (SAMHSA)","year":"2012"},{"key":"e_1_2_9_67_1","first-page":"1","volume-title":"TIP 42 substance abuse treatment for persons with co\u2010occurring disorders","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2013"},{"key":"e_1_2_9_68_1","first-page":"1","volume-title":"TIP 47 substance abuse: clinical issues in intensive outpatient treatment","author":"Substance Abuse and Mental Health Services Administration","year":"2013"},{"key":"e_1_2_9_69_1","volume-title":"TIP 48 managing depressive symptoms in substance abuse clients during early recovery","author":"Substance Abuse and Mental Health Services Administration","year":"2014"},{"key":"e_1_2_9_70_1","first-page":"1","volume-title":"TIP 37 Substance Abuse Treatment for Persons With HIV\/AIDS","author":"Substance Abuse and Mental Health Services Administration","year":"2013"},{"key":"e_1_2_9_71_1","first-page":"1","volume-title":"TIP 27 comprehensive case management for substance abuse treatment","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"key":"e_1_2_9_72_1","first-page":"1","volume-title":"TIP 45 \u2010 detoxification and substance abuse treatment","author":"Substance Abuse and Mental Health Services Administration","year":"2016"},{"key":"e_1_2_9_73_1","first-page":"1","volume-title":"TIP 51 \u2010 substance abuse treatment: addressing the specific needs of women a treatment improvement protocol","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"key":"e_1_2_9_74_1","first-page":"1","volume-title":"TIP 46 \u2010 substance abuse: administrative issues in outpatient treatment","author":"Substance Abuse and Mental Health Services Administration","year":"2012"},{"key":"e_1_2_9_75_1","first-page":"1","volume-title":"Service delivery for people with co\u2010existing mental health and addiction problems: integrated solutions","author":"Ministry of Health","year":"2010"},{"key":"e_1_2_9_76_1","first-page":"1","volume-title":"NSW clinical guidelines: treatment of opioid dependence \u2013 2018","author":"NSW Ministry of Health","year":"2018"},{"key":"e_1_2_9_77_1","first-page":"1","volume-title":"Canadian guidelines on alcohol use disorder among older adults","author":"Canadian Coalition for Seniors Mental Health","year":"2019"},{"key":"e_1_2_9_78_1","first-page":"1","volume-title":"Canadian Guidelines on Benzodiazepine Receptor Agonist Use Disorder Among Older Adults","author":"Canadian Coalition for Seniors Mental Health","year":"2019"},{"key":"e_1_2_9_79_1","first-page":"1","volume-title":"Canadian Guidelines on Cannabis Use Disorder Among Older Adults","author":"Canadian Coalition for Seniors Mental Health","year":"2019"},{"key":"e_1_2_9_80_1","first-page":"1","volume-title":"Canadian Guidelines on Opioid Use Disorder Among Older Adults","author":"Canadian Coalition for Seniors Mental Health","year":"2019"},{"key":"e_1_2_9_81_1","first-page":"1","volume-title":"VA\/DoD Clinical practice guideline for the management of substance use disorders","author":"Department of Veterans Affairs & Department of Defense","year":"2015"},{"key":"e_1_2_9_82_1","first-page":"1","volume-title":"Update of the Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders","author":"World Health Organization","year":"2015"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000260"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.07.010"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230801923702"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.554780"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1192\/bja.2017.14"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125317753340"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03613.x"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.09.016"},{"key":"e_1_2_9_91_1","volume-title":"Alcohol and other Drug Use: The Roles and Capabilities of Social Workers","author":"Galvani S","year":"2015"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2016.1170144"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2011.06.004"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2019.106249"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2018.1442951"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/hsc.12423"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13504","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dar.13504","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T03:08:00Z","timestamp":1692760080000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.13504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1111\/dar.13504"],"URL":"https:\/\/doi.org\/10.1111\/dar.13504","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"2022-01-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}